KRASG12C mutation

Photo of an elderly couple looking out over the sea
Mayo Clinic Cancer Center researchers identify promising drug to treat gastrointestinal cancers

Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.